Case Study 2:
Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient
has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart
disease. Drugs
...
Case Study 2:
Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient
has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart
disease. Drugs currently prescribed include the following:
Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun
Aspirin 81 mg daily
Metformin 1000 mg po bid
Glyburide 10 mg bid
Atenolol 100 mg po daily
Motrin 200 mg 1–3 tablets every 6 hours as needed for pain
About three out of four people who have a stroke for the first time have high blood
pressure. And an irregular atrial heart rhythm a condition called atrial fibrillation is present in
about one out of five strokes (American Heart Association, 2017). Approximately 33% of adults
in America are affected by hypertension sometimes called “high blood pressure” (Arcangelo,
Peterson, Wilbur, & Reinhold, 2017). According to National Stroke Association (2018), High
blood pressure, atrial fibrillation (AFib), high cholesterol, diabetes and circulation problems are
all medical risk factors, which are controllable, for stroke.
Age: Pharmacokinetic and Pharmacodynamics Process
Age should be taken into consideration when providers prescribe medications for the
elderly population. Scondotto et al., (2018) study show there are various homeostatic changes
that occur in the human body such as a reduction in the homeostatic ability as the individual’s
age increases. The increasing age affects the renal system of the individual. Reduction in
nephrons and hyalinization leads to reduced blood flow in the body (Scondotto et al., 2018).
Adverse drug reactions increases in pharmacodynamics and a decrease of pharmacokinetic with
an elderly population (Arcangelo et al., 2017). Pharmacokinetic changes include a reduction in
renal and hepatic clearance and an increase in the volume of distribution of lipid soluble drugs
(hence prolongation of elimination half-life) whereas pharmacodynamics changes involve altered
(usually increased) sensitivity to several classes of drugs such as anticoagulants, cardiovascular
and psychotropic drugs (Mangoni & Jackson, 2004).
Impact on Patient’s Drug Therapy
Pharmacokinetics is the body’s effect on a drug while Pharmacodynamics is the drug
effect on the body (Arcangelo et al., 2017). Managing atrial fibrillation (AF) requires three key
components that include preventing TIA
[Show More]